Back to Search Start Over

Evaluation of Liver Graft Donation After Euthanasia.

Authors :
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Service de chirurgie et transplantation abdominale
van Reeven, Marjolein
Gilbo, Nicholas
Monbaliu, Diethard
van Leeuwen, Otto B
Porte, Robert J
Ysebaert, Dirk
van Hoek, Bart
Alwayn, Ian P J
Meurisse, Nicolas
Detry, Olivier
Coubeau, Laurent
Ciccarelli, Olga
Berrevoet, Frederik
Vanlander, Aude
IJzermans, Jan N M
Polak, Wojciech G
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Service de chirurgie et transplantation abdominale
van Reeven, Marjolein
Gilbo, Nicholas
Monbaliu, Diethard
van Leeuwen, Otto B
Porte, Robert J
Ysebaert, Dirk
van Hoek, Bart
Alwayn, Ian P J
Meurisse, Nicolas
Detry, Olivier
Coubeau, Laurent
Ciccarelli, Olga
Berrevoet, Frederik
Vanlander, Aude
IJzermans, Jan N M
Polak, Wojciech G
Source :
JAMA Surgery, Vol. 155, no. 10, p. 917-924 (2020)
Publication Year :
2020

Abstract

IMPORTANCE: The option of donating organs after euthanasia is not well known. Assessment of the results of organ transplants with grafts donated after euthanasia is essential to justify the use of this type of organ donation. OBJECTIVES: To assess the outcomes of liver transplants (LTs) with grafts donated after euthanasia (donation after circulatory death type V [DCD-V]), and to compare them with the results of the more commonly performed LTs with grafts from donors with a circulatory arrest after the withdrawal of life-supporting treatment (type III [DCD-III]). DESIGN, SETTING, AND PARTICIPANTS: This retrospective multicenter cohort study analyzed medical records and LT data for most transplant centers in the Netherlands and Belgium. All LTs with DCD-V grafts performed from the start of the donation after euthanasia program (September 2012 for the Netherlands, and January 2005 for Belgium) through July 1, 2018, were included in the analysis. A comparative cohort of patients who received DCD-III grafts was also analyzed. All patients in both cohorts were followed up for at least 1 year. Data analysis was performed from September 2019 to December 2019. EXPOSURES: Liver transplant with either a DCD-V graft or DCD-III graft. MAIN OUTCOMES AND MEASURES: Primary outcomes were recipient and graft survival rates at years 1, 3, and 5 after the LT. Secondary outcomes included postoperative complications (early allograft dysfunction, hepatic artery thrombosis, and nonanastomotic biliary strictures) within the first year after the LT. RESULTS: Among the cohort of 47 LTs with DCD-V grafts, 25 organ donors (53%) were women and the median (interquartile range [IQR]) age was 51 (44-59) years. Among the cohort of 542 LTs with DCD-III grafts, 335 organ donors (62%) were men and the median (IQR) age was 49 (37-57) years. Median (IQR) follow-up was 3.8 (2.1-6.3) years. In the DCD-V cohort, 30 recipients (64%) were men, and the median (IQR) age was 56 (48-64) years. Recipient survival

Details

Database :
OAIster
Journal :
JAMA Surgery, Vol. 155, no. 10, p. 917-924 (2020)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1288277362
Document Type :
Electronic Resource